Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years

被引：0
|
作者：
Horinouchi, H. [1 ]
Ohe, Y. [1 ]
Yamanaka, Y. [2 ]
Kurata, T. [2 ]
Watanabe, K. [3 ]
Hosomi, Y. [3 ]
Nakahara, Y. [4 ]
Asao, T. [5 ]
Saeki, S. [6 ]
Tsubata, Y. [7 ]
Fujita, Y. [8 ]
Konishi, J. S. [9 ]
Mizugaki, H. [10 ]
Ohuchi, M. [11 ]
Yagishita, S. [11 ]
Hamada, A. [11 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Kansai Med Univ Hosp, Osaka, Japan
[3] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[4] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan
[5] Juntendo Univ Hosp, Tokyo, Japan
[6] Kumamoto Univ Hosp, Kumamoto, Japan
[7] Shimane Univ, Fac Med, Matsue, Shimane, Japan
[8] Jikei Univ, Sch Med, Tokyo, Japan
[9] Hokkaido Univ, Fac Med, Sapporo, Hokkaido, Japan
[10] JFCR, Canc Inst Hosp, Tokyo, Japan
[11] Natl Canc Ctr, Res Inst, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Pembrolizumab; pharmacokinetics; Elderly;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-08
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [21] A Phase II Trial of Gefitinib Monotherapy in Chemotherapy-Naive Patients of 75 Years or Older with Advanced Non-small Cell Lung Cancer
    Ebi, Noriyuki
    Semba, Hiroshi
    Tokunaga, Sho J. I.
    Takayama, Koichi
    Wataya, Hiroshi
    Kuraki, Takashige
    Yamamoto, Hidehiko
    Akamine, Shin J. I.
    Okamoto, Isamu
    Nakanishi, Yoichi
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) : 1166 - 1171
  • [22] Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer
    Zhang, Panpan
    Ma, Minting
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Zhang, Jie
    Wu, Di
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Han, Sen
    Long, Jieran
    Wang, Yang
    Zhang, Ziran
    Hao, Qianyun
    Fang, Jian
    HELIYON, 2024, 10 (04)
  • [23] Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
    Burgos-San Jose, Amparo
    Colomer-Aguilar, Claudia
    Martinez-Caballero, Daniel
    Massuti-Sureda, Bartomeu
    FARMACIA HOSPITALARIA, 2021, 45 (03) : 121 - 125
  • [24] Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence
    Rihawi, Karim
    Gelsomino, Francesco
    Sperandi, Francesca
    Melotti, Barbara
    Fiorentino, Michelangelo
    Casolari, Laura
    Ardizzoni, Andrea
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (09) : 353 - 373
  • [25] Pembrolizumab - Subsequent Lines in Non-Small Cell Lung Cancer: The Experience of a Tertiary Hospital
    China Pereira, N.
    Mendes, A.
    Reis, D.
    Dias, M.
    Coutinho, D.
    Costa, T.
    Silva, E.
    Campainha, S.
    Conde, S.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1072 - S1072
  • [26] Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustments
    Gower, Arjan
    Garon, Edward B.
    TRANSLATIONAL CANCER RESEARCH, 2022,
  • [27] The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancer
    Alexander, Mariam
    Ko, Brian
    Lambert, Remy
    Gadgeel, Shirish
    Halmos, Balazs
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 137 - 147
  • [28] Trousseau's syndrome in a non-small cell lung cancer patient aggravated by pembrolizumab
    Zhao, Lihong
    Zheng, Hong
    Zhu, Liqin
    Jiang, Ping
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 233 - 238
  • [29] Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study
    Luciani, Andrea
    Marra, Antonio
    Toschi, Luca
    Cortinovis, Diego
    Fava, Sergio
    Filipazzi, Virginio
    Tuzi, Alessandro
    Cerea, Giulio
    Rossi, Sabrina
    Perfetti, Vittorio
    Rossi, Antonio
    Giannetta, Laura
    Sala, Luca
    Finocchiaro, Giovanna
    Pizzutilo, Elio Gregory
    Carelli, Stephana
    Agustoni, Francesco
    Cergnul, Massimiliano
    Zonato, Sabrina
    Siena, Salvatore
    Bidoli, Paolo
    Ferrari, Daris
    CLINICAL LUNG CANCER, 2020, 21 (06) : E567 - E571
  • [30] Pembrolizumab in adjuvant therapy in non-small cell lung cancers
    Lefevre, Antoine
    Tissot, Claire
    BULLETIN DU CANCER, 2024, 111 (04) : 334 - 336
12345